The Lab-Pharmacy Nexus: Unveiling the convergence of scientific research and medication management
Keywords:
Laboratories, Pharmacies, Interplay, Lab-Pharmacy Nexus, LinkageAbstract
The synergies and vital interdependence between scientific research labs and pharmacies within the healthcare ecosystem have been thoroughly explored in this topic. Scientific research labs were portrayed as centers of creativity, experimentation, and cross-disciplinary cooperation that shaped how we perceive the natural world. Pharmacies were acknowledged as essential to patient care for their ability to dispense prescription drugs, promote health, and guarantee regulatory compliance. The discussion shed light on situations in which miscommunication between pharmacies and labs resulted in avoidable mistakes in medicine administration. The story went on to highlight the growing importance of pharmacists in the monitoring of therapeutic drugs, chronic illness care, and diagnostics. The need for collaboration between lab technicians and pharmacists was emphasized as a means of promoting innovation, managing the challenges associated with medication monitoring, and guaranteeing the best possible outcomes for patients. This comprehensive investigation highlights how important it is to collaborate seamlessly in order to promote patient safety, advance healthcare innovation, and improve the standard of care as a whole.
Downloads
References
Schiff, G. D., Klass, D., Peterson, J., Shah, G., & Bates, D. W. (2003). Linking laboratory and pharmacy: opportunities for reducing errors and improving care. Archives of internal medicine, 163(8), 893-900.
Woodcock, J., & Woosley, R. (2008). The FDA critical path initiative and its influence on new drug development. Annual review of medicine, 59, 1–12. https://doi.org/10.1146/annurev.med.59.090506.155819
Schiff GD, Aggarwal HC, Kumar S, McNutt RA. Prescribing potassium despite hyperkalemia: medication errors uncovered by linking laboratory and pharmacy information systems. Am J Med. 2000;109:494-497.
Chertow GM, Lee J, Kuperman GJ, et al. Guided medication dosing for inpatients with renal insufficiency. JAMA. 2001;286:2839-2844.
Bates DW, Cullen D, Laird N, et al. Incidence of adverse drug events and potential adverse drug events: implications for prevention. JAMA. 1995; 274:29-34.
Gandhi TK, Burstin HR, Cook EF, et al. Drug complications in outpatients. J Gen Intern Med. 2000;15:149-154.
President’s Advisory Committee on Consumer Protection and Quality in Healthcare. Building the capacity to improve quality: investing in information systems. In: Quality First: Better Health Care for All Americans. Silver Spring, Md: Agency for Healthcare Research and Quality Publications Clearinghouse; 1998:chap 14.
Balas EA, Austin SM, Mitchell JA, Ewigman BG Bopp KD, Brown GD. The clinical value of computerized information services: areview of 98randomized clinical trials. Arch Fam Med 1996;5 271-278.
Berwick DM, Nolan TW. Overview: cooperating for improvement. Jt Comm J Qual Improv. 1995; 21:573-577.
David D. Pope, PharmD, CDE (2023). Pharmacies and Labs Must Work Together to Accelerate Test and Treat Opportunities, Enhance Patient Care Equity, Improve Health Outcomes. Pharmacies and Labs Must Work Together to Accelerate Test and Treat Opportunities, Enhance Patient Care Equity, Improve Health Outcomes (pharmacytimes.com).
Perry MJ. Chart of the Day… or Century? American Enterprise Institute. January 11, 2019. Accessed September 27, 2023. https://www.aei.org/carpe-diem/chart-of-the-day-or-century/#:~:text=During%20the%20most%20recent%2021,average%20hourly%20earnings%20(wages).
Spicer J. Making patient care easier under multiple managed care plans. Fam Pract Manage. 1998;5(2):38-53.
Helfand M, Redfern CC, for the American College of Physicians. Clinical guideline, part 2 Screening for thyroid disease: an update. Ann Intern Med. 1998;129:144-158.
Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35)prospective observational study. BMJ. 2000; 321:405-412.
Aronoff GR, Bennett WM. eds. Drug Prescribing in Renal Failure: Dosing Guidelines for Adults. 4th ed. Philadelphia, Pa: ACP-ASIM; 1999.
Rodighiero V. Effects of liver disease on pharmacokinetics: an update. Clin Pharmacokinet. 1999;37:399-431.
Centers for Disease Control and Prevention. Druginduced liver injury: a national and global problem. Westfields Conference Center, Chantilly, Va, February 12-13, 2001. Available at: http://www.fda.gov/cder/livertox/default.htm. Accessed January 25, 2003.
Berenbrok LA, Tang S, Gabriel N, et al. Access to community pharmacies: A nationwide geographic information systems cross-sectional analysis. Sci and Pract. 2022;62(6):P1816-1822. doi:10.1016/j.japh.2022.07.003
Retail Health and Wellness Services Surge in Popularity, Driving Significant Gains in Pharmacy Customer Satisfaction, JD Power Finds. News release. JD Power. July 28, 2021. Accessed September 27, 2023. https://www.jdpower.com/business/press-releases/2021-us-pharmacy-study
Provider Status. Ohio Pharmacists Association. Accessed September 27, 2023. https://www.ohiopharmacists.org/aws/OPA/pt/sp/provider-status
Kaplowitz N. Drug-induced liver disorders: im- plications for drug development and regula- tion. Drug Saf. 2001;24:483-490.
Sundar S, Burma DP, Vaish SK. Digoxin toxic- ity and electrolytes: a correlative study. Acta Car- diol. 1983;38:115-123.
Young DS. Effects of Preanalytical Variables on Clinical Lab Tests. 2nd ed. Washington, DC: American Assocation for Clinical Chemistry Press; 1997.
Gronroos PE, Irjala KM, Huupponen RK, Schei- nin H, Forsstrom J, Forsstrom JJ. A medication database: a tool for detecting drug interactions in hospital. Eur J Clin Pharmacol. 1997;53:13- 17.
Forsstrom JJ, Gronroos P, Irjala K, Heiskanen J, Torniainen K. Linking patient medication data with laboratory information system. Int J Biomed Comput. 1996;42:111-116.
Kailajarvi M, Takala T, Gronroos P, et al. Re- minders of drug effects on laboratory test re- sults. Clin Chem. 2000;46:1395-1400.
Bill Malone (2012). The Emergence of Lab-Pharmacy Partnerships. The Emergence of Lab-Pharmacy Partnerships | myADLM.org
Published
How to Cite
Issue
Section
Copyright (c) 2023 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
